V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214619 | 20129972 | 1.82 | 76.7 | Palliative (P) | 2017-07-14 | 2017-07-25 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100602166 |
| 20214622 | 20129973 | 1.62 | 54.6 | Palliative (P) | 2020-11-15 | 2020-11-18 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101466727 |
| 20214624 | 20129974 | 1.62 | 80.95 | Palliative (P) | 2019-04-05 | 2019-04-12 | EOX | 2 | N | OXALIPLATIN + RALTITREXED | 100666496 |
| 20214626 | 20129975 | 1.78 | 57.05 | Neo-adjuvant (N) | 2013-12-01 | 2016-08-15 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101834859 |
| 20214627 | 20129976 | 1.83 | 91.2 | Curative (C) | 2018-08-05 | 2019-03-10 | Oxaliplatin + Raltitrexed | 2 | N | OXALIPLATIN + RALTITREXED | 101833304 |
| 20214629 | 20129977 | 1.9 | 85 | Palliative (P) | 2016-08-14 | 2016-09-29 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101453309 |
| 20214633 | 20129978 | 1.82 | 51.35 | Palliative (P) | null | 2016-03-21 | Trial Unspecified | N | Y | CETUXIMAB + IRINOTECAN + MDG | 100171147 |
| 20214635 | 20129979 | 1.65 | 76.2 | 03 | 2017-07-03 | 2017-07-16 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101666984 |
| 20214638 | 20129980 | 1.58 | 71.9 | Adjuvant (A) | 2018-08-01 | 2018-08-28 | Sorafenib | 02 | Y | SORAFENIB | 100760068 |
| 20214639 | 20129981 | 1.88 | 54 | Curative (C) | null | 2017-01-01 | EOX | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101060334 |
| 20214641 | 20129982 | 1.53 | 67.8 | null | 2020-01-17 | 2020-01-17 | Cetuximab + FOLFIRI cycle1 | N | null | CETUXIMAB + IRINOTECAN + MDG | 100831800 |
| 20214642 | 20129983 | 1.57 | 95.7 | null | 2020-02-27 | 2020-03-14 | Sorafenib | 99 | null | SORAFENIB | 100804160 |
| 20214643 | 20129984 | 1.9 | 108.1 | null | 2016-02-02 | 2016-03-15 | EOX | 02 | N | TRIAL | 101108529 |
| 20214644 | 20129985 | 1.63 | 68.4 | Palliative (P) | null | 2021-02-15 | Sorafenib | 99 | N | SORAFENIB | 100175072 |
| 20214645 | 20129986 | 1.76 | 80 | null | 2017-09-13 | 2017-09-29 | Sorafenib | 02 | null | SORAFENIB | 100980522 |
| 20214646 | 20129987 | null | 86.3 | Curative (C) | 2017-01-19 | 2017-01-21 | EOX | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100200936 |
| 20214648 | 20129988 | 1.79 | 63 | null | 2018-02-16 | 2018-02-20 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100097274 |
| 20214651 | 20129989 | 1.66 | 58.5 | Palliative (P) | 2017-03-25 | 2017-04-22 | Sorafenib | 02 | N | SORAFENIB | 100533699 |
| 20214654 | 20129990 | 1.69 | 89 | Palliative (P) | 2018-11-18 | 2018-12-09 | Trial Unspecified | 99 | N | CETUXIMAB + IRINOTECAN + MDG | 100372165 |
| 20214655 | 20129991 | 1.63 | 61 | null | 2017-08-19 | 2017-10-05 | EOX | null | null | CETUXIMAB + IRINOTECAN + MDG | 101085675 |
| 20214656 | 20129992 | 1.49 | 136 | Adjuvant (A) | 2018-12-23 | 2018-12-24 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100471389 |
| 20214658 | 20129993 | 1.71 | 100 | Adjuvant (A) | 2018-05-20 | 2018-08-12 | GO2 TRIAL | 02 | null | TRIAL | 101467283 |
| 20214659 | 20129994 | 1.9 | 85.6 | Adjuvant (A) | 2020-05-06 | 2020-05-10 | EOX | 01 | N | SORAFENIB | 100013801 |
| 20214661 | 20129995 | 1.59 | 52.2 | null | 2017-10-23 | 2018-05-21 | Trial Unspecified | N | null | TRIAL | 100720624 |
| 20214666 | 20129996 | 1.69 | 72 | Disease modification (D) | 2018-06-18 | 2019-04-19 | EOX | 02 | Y | EOX | 101811456 |
| 20214668 | 20129997 | 1.69 | 79 | Adjuvant (A) | 2019-04-05 | 2019-06-30 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101222197 |
| 20214670 | 20129998 | 1.71 | 61.6 | null | 2018-12-25 | 2018-12-25 | EOX | 02 | N | EOX | 101009970 |
| 20214672 | 20129999 | 1.69 | 58 | Disease modification (D) | 2019-07-21 | 2019-08-29 | EOX | 02 | N | SORAFENIB | 101336542 |
| 20214673 | 20130000 | 1.74 | 65 | Curative (C) | 2018-04-06 | 2018-04-06 | CAPECITABINE + RT | Y | Y | CAPECITABINE + RT | 100388093 |
| 20214674 | 20130001 | 1.75 | 69.6 | Neo-adjuvant (N) | 2019-10-24 | 2019-11-17 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100807305 |
| 20214675 | 20130002 | 1.64 | 75.3 | Palliative (P) | 2019-08-04 | 2019-08-11 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100987455 |
| 20214677 | 20130003 | 1.68 | 62.5 | Palliative (P) | 2019-03-22 | 2019-03-25 | EOX | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100153133 |
| 20214679 | 20130004 | 1.55 | 89.9 | Palliative (P) | 2020-01-19 | 2020-02-07 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101421218 |
| 20214681 | 20130005 | 1.55 | 92 | Palliative (P) | 2019-09-17 | 2019-09-17 | EOX | N | N | EOX | 101226955 |
| 20214684 | 20130006 | 1.6 | 42 | Palliative (P) | 2017-04-08 | 2017-04-22 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101868005 |
| 20214685 | 20130007 | 0 | 65 | Curative (C) | 2019-06-01 | 2020-10-23 | EOX | 02 | Y | CAPECITABINE + RT | 100944557 |
| 20214686 | 20130008 | 1.7 | 77 | null | 2020-06-26 | 2020-06-26 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101730031 |
| 20214687 | 20130009 | 1.7 | 59.9 | Curative (C) | 2019-05-08 | 2019-09-02 | FLUOROURACIL + IRINOTECAN + Panitumumab | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100121366 |
| 20214688 | 20130010 | 1.53 | 74.3 | null | 2018-08-12 | 2018-08-29 | EOX | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100372480 |
| 20214689 | 20130011 | 1.56 | 46.9 | Palliative (P) | 2016-03-14 | 2016-03-27 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101705416 |
| 20214691 | 20130012 | 1.74 | 72 | null | 2020-12-12 | 2020-12-12 | CAPECITABINE + RT | N | null | CAPECITABINE + RT | 101706293 |
| 20214692 | 20130013 | 1.6 | 89.5 | Palliative (P) | 2020-04-15 | 2020-04-20 | EOX | N | Y | CAPECITABINE + RT | 100944929 |
| 20214695 | 20130014 | 1.71 | 89.5 | Palliative (P) | 2017-11-28 | 2017-12-05 | GO2 TRIAL | Y | N | TRIAL | 101773674 |
| 20214697 | 20130015 | 1.71 | null | Palliative (P) | 2017-07-19 | 2017-07-27 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + IRINOTECAN + MDG | 101393969 |
| 20214698 | 20130016 | 1.7 | 74.9 | Palliative (P) | 2017-05-29 | 2017-06-10 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101735652 |
| 20214699 | 20130017 | 1.58 | 76.3 | Neo-adjuvant (N) | 2018-11-11 | 2018-11-11 | Capecitabine 35days + RT | N | Y | CAPECITABINE + RT | 101334311 |
| 20214701 | 20130018 | 1.64 | 61.2 | Palliative (P) | 2018-05-02 | 2018-10-29 | Trial Unspecified | N | N | TRIAL | 101411562 |
| 20214707 | 20130019 | 1.76 | 84.3 | Palliative (P) | 2021-02-25 | 2021-02-25 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100470515 |
| 20214708 | 20130020 | 1.71 | 85.6 | Palliative (P) | 2017-09-01 | 2017-09-13 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101265338 |
| 20214710 | 20130021 | 1.78 | 86.6 | Palliative (P) | 2017-08-22 | 2017-09-03 | Sorafenib | 01 | N | SORAFENIB | 100923969 |